Antigen-Presenting Synthetic Surfaces, Covalently Functionalized Surfaces, Activated T Cells, and Uses Thereof

Bispecific HER2 antibodies and methods of use

Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof

A33 antibody compositions and methods of using the same in radioimmunotherapy

Polypeptides which bind to interleukin-6 receptor (IL-6R)

Anti-IL13 antibodies and uses thereof

Constitutively active chimeric cytokine receptors

Anti-BCMA chimeric antigen receptors

Fusion proteins for treating cancer and related methods

Mesothelin binding proteins

MONOCLONAL ANTIBODIES AGAINST BCMA

Compositions and methods for treatment of diseases involving CXCL1 function

CHIMERIC ANTIGEN RECEPTOR COMPOSITIONS

Humanized antibodies against CEACAM1

Neutralizing human anti-CD27 antibodies

PROTEINS BINDING NKG2D, CD16 AND A TUMOR-ASSOCIATED ANTIGEN

Anti-ErbB3 antibodies and uses thereof

Nucleic acid molecules encoding chimeric antigen receptors targeting B-cell maturation antigen and uses thereof

Methods of using chimeric antigen receptors targeting B-cell maturation antigen and uses thereof

ARTICLES AND METHODS DIRECTED TO PERSONALIZED THERAPY OF CANCER

Bispecific antibodies against HER2 and CD3

Anti-TIGIT antibodies

Trifunctional T cell-antigen coupler and methods and uses thereof

Methods of treatments using chimeric antigen receptors targeting G-protein coupled receptor

Nucleic acid molecules encoding chimeric antigen receptors targeting G-protein coupled receptor

Chimeric antigen receptors targeting G-protein coupled receptor and uses thereof

Plectin-1 binding antibodies and uses thereof

Cancer treatments

GAMMA DELTA T CELLS AND USES THEREOF

Heterodimeric antibody Fc-containing proteins and methods for production thereof

CRTAM antibodies and methods of treating cancer

ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2

APOPTOTIC CELL-MEDIATED INDUCTION OF ANTIGEN SPECIFIC REGULATORY T-CELLS FOR THE THERAPY OF AUTOIMMUNE DISEASES IN ANIMALS AND HUMANS

Universal platform for preparing an inhibitory chimeric antigen receptor (iCAR)

Anti-HER2 Antibodies and Immunoconjugates

Anti-CD276 polypeptides, proteins, and chimeric antigen receptors

B7-H4 antibodies and methods of use thereof

Novel Senolytic Peptides

Materials and Methods for Eliciting Targeted Antibody Responses In Vivo

Uses of indolinone compounds

THERAPEUTIC ANTIBODIES BASED ON MUTATED IGG HEXAMERS

ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

CHIMERIC ANTIGEN RECEPTORS (CAR) TO SELECTIVELY TARGET PROTEIN COMPLEXES

Pyrrolobenzodiazepine conjugates

Chimeric antigen and T cell receptors and methods of use

Systems and methods for miniaturized antenna for wireless power transmissions

MUC1* antibodies

Means and methods for counteracting myeloproliferative or lymphoproliferative disorders

Antibodies to TIP1 and methods of use thereof

MODULATING THE IMMUNE RESPONSE USING ANTIBODY-DRUG CONJUGATES

Anti-CD123 antibodies and conjugates and derivatives thereof

BTLA agonist antibodies and uses thereof

Method of reducing mesothelin-expressing tumor burden by administration of T cells comprising mesothelin-targeted chimeric antigen receptors

Methods of inducing complement activity

BCL-XL Inhibitory Compounds and Antibody Drug Conjugates Including the Same

Constructs having a SIRP-α domain or variant thereof

METHOD FOR THE TREATMENT OR PREVENTION OF INFECTION-RELATED IMMUNE CONDITIONS USING A COMPOSITION COMPRISING IGM

Methods of treating cancer using compositions of antibodies and carrier proteins with antibody pretreatment

Anti-age antibodies for treating inflammation and auto-immune disorders

T-cells expressing anti-LIV1 chimeric antigen receptor

GPRC5D chimeric antigen receptors and cells expressing the same

Anti-c-Met antibody and use thereof

Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof

Single chain variable fragment CD3 binding proteins

Immunotoxins with albumin binding domain

Antibodies that bind colony stimulating factor 1 receptor (CSF1R)

Anti-epidermal growth factor receptor (EGFR) antibodies

Markers of acute myeloid leukemia stem cells

Chimeric antigen receptors (CARs), compositions and methods thereof

Adenovirus armed with bispecific T cell activator

Methods and materials for treating cancer

Polynucleotides encoding humanized antibodies against CEACAM1

Tumor selective macropinocytosis-dependent rapidly internalizing antibodies

Chimeric antigen receptors and CAR-T cells that bind CXCR5 and methods of use thereof to treat medical disorders

PROTEINS BINDING NKG2D, CD16, AND EGFR, HLA-E, CCR4, OR PD-L1

Bi-specific monovalent diabodies that are capable of binding CD19 and CD3, and uses thereof

Anti-PD1 antibodies and their use as therapeutics and diagnostics

Checkpoint inhibitor and a whole cell for use in cancer therapy

Checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy

Checkpoint inhibitor and a whole cell for use in cancer therapy

Combination therapy with Axl inhibitor and immune checkpoint modulator or oncolytic virus

DETECTING CANCER WITH ANTI-CXCL13 AND ANTI-CXCR5 ANTIBODIES

Cytotoxic and anti-mitotic compounds, and methods of using the same

Extra luminal scaffold

Antibodies capable of binding HLA-A2/TyrD in an HLA restricted manner and uses thereof

Anti-CD47 antibodies and uses thereof

Multi-chain polypeptide-containing tri-specific binding molecules

Engineered T cell receptors and immune therapy using the same

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

IDENTIFICATION OF VSIG8 AS THE PUTATIVE VISTA RECEPTOR (V-R) AND USE THEREOF TO PRODUCE VISTA/VSIG8 AGONISTS AND ANTAGONISTS

Heterodimeric antibodies that bind CD3 and CD38

Targeted drug delivery through affinity based linkers

Bispecific HER2 and CD3 binding molecules

BAFF-R BISPECIFIC T-CELL ENGAGER ANTIBODY

Tri-specific binding molecules that specifically bind to multiple cancer antigens

Biparatopic polypeptides antagonizing Wnt signaling in tumor cells

Antigen binding proteins

Twin immune cell engager

Targeting gene amplification in cancer using triplex formation as a therapeutic strategy

Modified J-chain

Anti-CD3-binding domains and antibodies comprising them, and methods for their generation and use

Anti-PD-1 antibodies

Diagnosis and treatment of cancer

Compositions and methods for inhibition of the lncRNA SAF to drive apoptotic cell death in human immunodeficiency virus (HIV) infected human macrophages

ANTI-OX40 ANTIBODIES AND THEIR USES

Method for treating cancer using CD14 antagonists

Hetero-dimeric multi-specific antibody format targeting at least CD3 and HSA

Ultralong complementarity determining regions and uses thereof

Methods and compositions involving interleukin-6 receptor alpha-binding single chain variable fragments

COMMON LIGHT CHAINS AND METHODS OF USE

Antibodies and chimeric antigen receptors specific for CD19

Bispecific binding proteins and uses thereof

STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF

Method of treating renal cancer using carbonic anhydrase IX (G250) antibodies

VARIANTS OF CD38 ANTIBODY AND USES THEREOF

CD123 binding proteins and related compositions and methods

Compositions and methods for inhibition of MICA/B shedding

Development of masked therapeutic antibodies to limit off-target effects

Antibodies specific for IL-21 and uses thereof

PERTUZUMAB VARIANTS AND EVALUATION THEREOF

PROTEINS BINDING NKG2D, CD16 AND A TUMOR-ASSOCIATED ANTIGEN

INHIBITOR OF SUV39H1 HISTONE METHYLTRANSFERASE FOR USE IN CANCER COMBINATION THERAPY

Anti-PD-L1 antibodies and uses thereof

Bispecific antibodies to ROR1 and CD3

Tri-specific antibodies

Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers

PROTEINS BINDING NKG2D, CD16 AND ROR1 OR ROR2

Compositions and methods for treating cancer with anti-CD22 immunotherapy

Anti-CLL-1 antibodies and methods of use

Anti-CD33 antibodies and uses thereof

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

INHIBITOR OF SUV39H1 HISTONE METHYLTRANSFERASE FOR USE IN CANCER COMBINATION THERAPY

Nucleic acid biomarker and use thereof

Cytotoxic antibody

Method for treating glioblastoma or glioma with antibody constructs for EGFRVIII and CD3

Trispecific anti-CD38, anti-CD28, and anti-CD3 binding proteins and methods of use for treating viral infection

Anti-TREM2 antibodies and related methods

Chimeric antigen receptor (CAR) comprising a CD19-binding domain

Antibodies that bind cell surface GRP78

T-cell modulatory multimeric polypeptides and methods of use thereof

Peptide for toll-like receptor (TLR) inhibition and pharmaceutical composition comprising same

Light chain variable regions

Monoclonal Antibodies to Programmed Death 1 (PD-1)

ANTI-B-CELL MATURATION ANTIGEN CHIMERIC ANTIGEN RECEPTORS WITH HUMAN DOMAINS

Compositions and methods of cellular immunotherapy

METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES

Therapeutic molecules binding PSMA

Methods of treating cancer using antibodies and molecules that immunospecifically bind to BTN1A1

Anti-TREM1 antibodies and methods of use thereof

Cysteine modified antibody-drug conjugate and preparation method thereof

ANTIBODY DRUG CONJUGATES

Chimeric antibody immune effector cell engagers and methods of use thereof

Bispecific heterodimeric fusion proteins containing IL-15-IL-15Ralpha Fc-fusion proteins and immune checkpoint antibody fragments

CYTOTOXICITY-INDUCING THERAPEUTIC AGENT

Compositions and methods for treating cancer with anti-CD19 immunotherapy

Compounds and methods for treating pain

Methods and antibody compositions for tumor treatment

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

Anti-IGF-I receptor antibodies, encoding nucleic acid molecules and methods of using said antibodies

Compositions and methods for targeted immunomodulatory antibodies and fusion proteins

Anti-PD-1 antibodies and uses thereof

Methods of suppressing rheumatoid arthritis using an anti-IL-6 antibody

Antibody/T-cell receptor chimeric constructs and uses thereof

Compositions and methods for treating cancer with anti-CD19/CD20 immunotherapy

Selective elimination of erosive cells

COMPOSITIONS AND METHODS FOR TARGETING AND KILLING ALPHA-V BETA-3-POSITIVE CANCER STEM CELLS (CSCS) AND TREATING DRUG RESISTANT CANCERS

Anti-CEACAM1 antibody and use thereof

Anti-HER2 biparatopic antibody-drug conjugates and methods of use

Chimeric antigen receptors targeting B-cell maturation antigen

T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS

Anti-CEACAM5 antibodies and uses thereof

Engineered immunoglobulin Fc polypeptides displaying improved complement activation

Anti-CXCR4 antibodies and antibody-drug conjugates

Antibodies specific to delta 1 chain of T cell receptor

CHIMERIC ANTIGEN RECEPTORS (CAR) AND METHODS FOR MAKING AND USING THE SAME

Methods and compositions for enhancing the potency of superantigen mediated cancer immunotherapy

Compositions and methods for treating cancer with anti-CD33 immunotherapy

Deimmunized Serum-Binding Domains and Their Use in Extending Serum Half-Life

Photosensitizing antibody-fluorophore conjugates

ANTIBODY HEAVY CHAIN VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR

Anti-TIGIT antigen-binding proteins and methods of use thereof

CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS

Therapeutic CD47 antibodies

MODULATION OF THE IMMUNE RESPONSE

Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1

Chimeric antigen receptors targeting B-cell maturation antigen

Chimeric antigen receptors targeting B-cell maturation antigen

Chimeric antigen receptors targeting B-cell maturation antigen

Chimeric antigen receptors targeting B-cell maturation antigen

IgE antibodies for the inhibition of tumor metastasis

Bispecific EGFR/C-Met Antibodies

COMBINATION THERAPY OF CANCER WITH ANTI-ENDOGLIN ANTIBODIES AND ANTI-VEGF AGENTS

Photosensitizing antibody-fluorophore conjugates

Methods and compositions related to a tissue factor-targeting IGG3 immunoconjugates

Inhibition of Chemokine CCL7 or Receptor CCR3 of Same for the Treatment and Diagnosis of Prostate Cancer

Compositions and methods for targeting stromal cells for the treatment of cancer

Anti-CD47 monoclonal antibody and use thereof

CD20 scFv-ELPs methods and therapeutics

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

BCMA chimeric antigen receptors

ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE

Compounds

Anti-netrin-1 antibody

Cancer-cell-specific anti-TMEM-180 monoclonal antibody, anticancer drug, and cancer testing method

Methods and compositions for enhancing the potency of superantigen mediated cancer immunotherapy

Chimeric antigen receptors targeting b-cell maturation antigen

Chimeric antigen receptors targeting B-cell maturation antigen

Chimeric antigen receptors targeting B-cell maturation antigen

Chimeric antigen receptors targeting B-cell maturation antigen

Chimeric antigen receptors targeting B-cell maturation antigen

Chimeric antigen receptors targeting B-cell maturation antigen

Antibodies that bind to OX40 and their uses

CAR T therapy through uses of co-stimulation

Trifunctional T cell-antigen coupler and methods and uses thereof

ANTIBODIES AND ANTIBODY FRAGMENTS FOR SITE-SPECIFIC CONJUGATION

TRISPECIFIC ANTIGEN BINDING PROTEINS

Bispecific binding molecules that are capable of binding CD137 and tumor antigens, and uses thereof

COMBINATION OF AN ANTI-VEGFR-2 ANTIBODY AND AN ANTI-PD-L1 ANTIBODY FOR THE TREATMENT OF CANCER

Anti-CD19 humanized antibody and immune effector cell targeting cd 19

Trivalent, bispecific antibodies

NUCLEIC ACID ENCODING GENETICALLY ENGINEERED GROWTH FACTOR VARIANTS

IL2 and TNF mutant immunoconjugates

HER3 specific monoclonal antibodies for diagnostic and therapeutic use

Antibody specifically binding to PAUF protein and use thereof

Antibody constructs for CLDN18.2 and CD3

Antibody preparation

CHIMERIC ENGULFMENT RECEPTOR MOLECULES

ANTI-SIGLEC-8 ANTIBODIES AND METHODS OF USE THEREOF

Antigen binding molecules and methods of use thereof

Anti-OX40 antibodies and their uses

Cell injury inducing therapeutic drug for use in cancer therapy

Endoglin Antibodies

BISPECIFIC ANTIBODIES

Carbohydrate antibodies, pharmaceutical compositions and uses thereof

Production of immunotoxin D2C7—(scdsFv)—PE38KDEL

Single chain binding molecules comprising N-terminal ABP

Anti-PD-1 antibodies and their uses

Antibodies specific to human poliovirus receptor (PVR)

Treatment or prevention method of radiation damage by administration of IL-5 receptor alpha chain binding antibody

IL15/IL15Ralpha HETERODIMERIC Fc-FUSION PROTEINS

Anti-CD112R compositions and methods

V-C-FC-V-C ANTIBODY

Anti PD-1 antibodies

Malaria vaccine and methods for producing same

Humanized anti-CD19 antibody and use thereof with chimeric antigen receptor

ß-1,6-glucan therapeutic antibody conjugates

Anti oligosaccharide antibody

USE OF ANTI-PD-1 ANTIBODY IN COMBINATION WITH ANTI-CD27 ANTIBODY IN CANCER TREATMENT

PROTEINS BINDING PSMA, NKG2D AND CD16

Chimeric antigen receptors (CARs), compositions and methods thereof

Nucleic acid encoding anti-GM-CSF antibodies

VARIANTS OF CD38 ANTIBODY AND USES THEREOF

Modulation of stimulatory and non-stimulatory myeloid cells

CARBOHYDRATE CONTENT OF CTLA4 MOLECULES

CHIMERIC ANTIGEN RECEPTORS AND COMPOSITIONS AND METHODS OF USE THEREOF

Anti-NRP1 antibody screening method

Bispecific binding molecules binding to VEGF and Ang2

Method of treating cancer or depleting regulatory T cells in a subject by administering a human IGG1 anti-CD25 antibody

THERAPIES BASED ON CONTROL OF REGULATORY T CELL STABILITY AND FUNCTION VIA A NEUROPILIN-1:SEMAPHORIN AXIS

Methods of treating skin cancer by administering a PD-1 inhibitor

ErbB2 antibodies and uses therefore

Treatment of -associated Waldenstrom's macroglobulinemia with an anti-CXCR4 antibody

Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disorders

CS1-specific chimeric antigen receptor engineered immune effector cells

Monoclonal antibodies to progastrin and their uses

Synthetic library of specific binding molecules

Method for the treatment of malignancies

Glycan-interacting compounds and methods of use

HUMANIZED ANTIBODIES THAT BIND LGR5

Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis

BCMA (CD269) specific chimeric antigen receptors for cancer immunotherapy

Bispecific checkpoint inhibitor antibodies

HER3 inhibitor for modulating radiosensitivity

Monoclonal antibodies targeting epitopes of ASPH

Bispecific checkpoint inhibitor antibodies

Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof

Antibodies specific for CD3 and uses thereof

T cell recruiting polypeptides based on CD3 reactivity

ANTI-TIM3 ANTIBODIES AND METHODS OF USE

Nucleolin Antibodies

Therapy for metastatic urothelial cancer with the antibody-drug conjugate, sacituzumab govitecan (IMMU-132)

COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES

ANTI-NTB-A ANTIBODIES AND RELATED COMPOSITIONS AND METHODS

PROTEINS BINDING BCMA, NKG2D AND CD16

Oncolytic virotherapy and immunotherapy

TRAILshort antibody and methods of use

Chimeric antigen receptors against AXL or ROR2 and methods of use thereof

Methods of treating cancer in a subject having elevated ICOS and/or T-bet levels of CD+4 cells by administering an ICOS agonist

Anti-podocalyxin antibodies and methods of using the same

METHODS FOR FORMULATING ANTIBODY DRUG CONJUGATE COMPOSITIONS

Specific antibody drug conjugates (ADCs) having KSP inhibitors

DISTINGUISHING ANTAGONISTIC AND AGONISTIC ANTI B7-H1 ANTIBODIES

BCMA-targeting antibody and use thereof

Antibody targeting IL-13RA2 and use thereof

Antigen binding proteins that bind c-Met

Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof

ADOPTIVE TRANSFER OF CAR T CELLS WITH SURFACE-CONJUGATED DRUG-LOADED NANOPARTICLES AND USES THEREOF

Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM

Treatment of angiogenesis disorders